This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

Elispot looks at the T cell response and IGG/IGM looks at B cells/Antibodies. 

Some people don't produce antibodies and have a more active T cell response. 

In an ideal world to assess an infection, a practitioner should look at both sides of the immune system response, in other words, Eli-spot for the T cells/cellular response and IGG/IGM for humoral/B cell/antibody response.

To check for an active infection with the T cells, the Elispot is recommended.

Elispot-LTT tests:

For current active infections with:

Borrelia burgdorferi, Anaplasma, Ehrlichia, Chlamydia pneymoniae, Chlamydia trachomatis, Yersinia, Epstein-Barr Virus, Cytomegalovirus, Babesia, Bartonella, Mycoplasma and Varicella zoster virus .

• This test is highly sensitive and can detect even one single Borrelia burgdorferi-reactive T-cell. This is one of the most sensitive cellular assays available, as detection levels can be as low as one cell in 100,000. .
• The Elispot reflects chronic and recent Borrelia burgdorferi infections. .
• It is between 20 and 200 times more sensitive than a conventional ELISA test.
• The EliSpot displays similar sensitivity to an RTPCR (Real Time PCR) analysis, but detects the secreted protein instead of the mRNA (messenger RNA). .

This test can be helpful in monitoring therapeutic treatments. It should become negative about 4 to 8 weeks after the completion of an effective therapy.

Overview

Analytes Tested:

Bartonella henselae

Practical

ACD/CPDA vial

This sample requires a blood draw